4 Results for "

Gemigliptin

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Gemigliptin" in MCE Product Catalog:

Cat. No.: HY-14892
CAS No.: 911637-19-9
Synonyms: LC15-0444
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease Cancer

Gemigliptin (LC15-0444 ) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin exhibits potent anti-glycation properties. Gemigliptin can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14892A
CAS No.: 1374639-74-3
Purity:  98.17%
Synonyms: LC15-0444 tartrate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14892C
CAS No.: 1523530-62-2
Synonyms: LC15-0444 hydrochloride
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease Cancer

Gemigliptin hydrochloride is the hydrochloride salt of Gemigliptin (HY-14892). Gemigliptin hydrochloride is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin hydrochloride exhibits potent anti-glycation properties. Gemigliptin hydrochloride can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14892B
CAS No.: 1375415-82-9
Synonyms: LC15-0444 tartrate hydrate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Gemigliptin (LC15-0444 ) tartrate hydrate is a selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate hydrate exhibits potent anti-glycation properties. Gemigliptin tartrate hydrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...